Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy / 药学学报
Acta Pharmaceutica Sinica
;
(12): 1091-1098, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-259510
ABSTRACT
Current trends in nanotechnology and RNA interference technology have made the application of nanocarriers (NCS) as a novel gene and drug delivery systems very promising for the field of multidrug resistance (MDR) cancer treatment. Co-delivery of gene and chemotherapy drugs with NCS has a good synergistic effect compared with the traditional chemotherapy which can increase the amount of the drug distribution in target organ in order to reduce the toxic side effects thereby enhancing efficacy. Therefore, the advent of co-delivery systems with NCS especially in the clinical treatment of MDR has had a significant impact on the cancer treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Terapéutica
/
Portadores de Fármacos
/
Terapia Genética
/
Química
/
Sistemas de Liberación de Medicamentos
/
Resistencia a Múltiples Medicamentos
/
Resistencia a Antineoplásicos
/
Nanotecnología
/
ARN Interferente Pequeño
/
Interferencia de ARN
Límite:
Humanos
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS